Wordt geladen...
Quality of Life in SMA Patients Under Treatment With Nusinersen
Background: Spinal Muscular Atrophy (SMA) is a severe neurodegenerative disease, characterized by progressive muscle weakness and atrophy. The approval of the antisense oligonucleotide (ASO) nusinersen now provides an effective pharmacological approach with the potential to slow down or stop disease...
Bewaard in:
| Gepubliceerd in: | Front Neurol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039289/ https://ncbi.nlm.nih.gov/pubmed/33854472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.626787 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|